“We'll Assess how the commercialization of this substance fits in with our business product at Adastra in order to situation ourselves to guidance the desire for a secure provide of copyright,” mentioned chief executive officer Michael Forbes inside a news launch. The corporation explained to VICE Information it wouldn't be commenting even more